Card image cap

Gregg Harper's Public Statements on Issue: Drugs

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Date Title
10/25/2018 Walden and Harper on DOJ Appalachian Regional Prescription Opioid Strike Force
09/27/2018 Letter to the Hon. Kirstjen Nielsen, Secretary of Homeland Security - Efforts to Halt Trafficking of Deadly Fentanyl
09/27/2018 Letter to the Hon. Mike Pompeo, Secretary of State - Efforts to Halt Trafficking of Deadly Fentanyl
09/27/2018 Letter to Uttam Dhillon, Acting Director of the Drug Enforcement Administration - Efforts to Halt Trafficking of Deadly Fentanyl
08/02/2018 Letter to Saeed Motahari, President and Chief Executive Officer of Insys Therapeutics - Letters Continue Committee's Comprehensive Review of Opioid Epidemic
08/02/2018 Letter to Mark Trudeau, President and Chief Executive Officer of Mallinckrodt Pharmaceuticals - Greg Walden Presses Opioid Manufacturers About Their Role in Crisis
08/02/2018 Letter to Craig Landau, President and Chief Executive Officer of Purdue Pharma - Letters Continue Committee's Comprehensive Review of Opioid Epidemic
07/24/2018 Hearing of the Oversight and Investigations Subcommittee of the House Harper Committee - Opening Statement of Rep. Harper, Hearing on Examining Advertising and Marketing Practices Within the Substance Use Treatment Industry
06/08/2018 Letter to the Hon. Scott Gottlieb, Commissioner of Food and Drugs - Bipartisan E&C Leaders Request Information from FDA About Efforts to Stop the Importation of Illegal Opioids
05/29/2018 Letter to Eight Call Aggregators - Regarding their Practices and Reports of Patient Brokering
04/26/2018 Congressman Harper's Bipartisan Bill Advances to the Full Committee
04/18/2018 Opioid Epidemic
04/18/2018 E&C Leaders Comment on DEA Action to Help Combat the Opioid Crisis
03/18/2018 Walden, Burgess, and Harper on Trump Administration's Plan to Combat the Opioid Crisis
03/06/2018 Walden, Burgess, and Harper Comment on New CDC Report on Growing Concerns of Opioid Crisis
02/06/2018 DeGette and other Energy and Commerce Committee Leaders Call on DEA to "Stop Playing Games"
12/12/2017 #SubOversight Reviews Patient Brokering and Treatment Fraud Intensified by Opioid Crisis
04/26/2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA) - Sen. Cruz, Others Hammer FDA on Relaxed Standards for Abortion Drug
04/22/2014 Letter to Margaret Hamburg, Commissioner of US Food and Drug Administration - Committee Presses FDA for Documents On Trial Lawyers' Role in Proposed Changes to Generic Drug Labeling
arrow_upward